← Leaderboards
Irina G. Luzina
Baltimore Va Medical Center
$2,585,232
Attributed
$2,585,232
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $345.4K · FY2008–25$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,585,232 · 4
VA$0 · 3
By mechanism
R01$2,021,082 · 2
R56$339,900 · 1
R03$224,250 · 1
I01$0 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryRegulationMediatingFibrosisLungFutureCellsInflammationCytokineBaseInterleukinsPhenotypeCell TypeNuclearProductionCicatrixKidneyOrganTissuesLiverCollagenFibroblastsExtracellularBiology
Grant awards (21)
Taming IL-33 to Control Inflammation and Fibrosis$329,703
R01 · FY2025 · AR · contact PI
On- and Oï¬-Axis Control of Fibrosis by IL-33 and ST2$0
I01 · FY2025 · VA · contact PI
Taming IL-33 to Control Inflammation and Fibrosis$329,703
R01 · FY2024 · AR · contact PI
On- and Oï¬-Axis Control of Fibrosis by IL-33 and ST2$0
I01 · FY2024 · VA · contact PI
Taming IL-33 to Control Inflammation and Fibrosis$339,900
R01 · FY2023 · AR · contact PI
Taming IL-33 to Control Inflammation and Fibrosis$336,501
R01 · FY2022 · AR · contact PI
Taming IL-33 to Control Inflammation and Fibrosis$339,900
R01 · FY2021 · AR · contact PI
Taming IL-33 to Control Inflammation and Fibrosis$339,900
R56 · FY2020 · AR · contact PI
The Central Role of IL-33 in Immune-Mediated Scarring$0
I01 · FY2020 · VA · contact PI
The Central Role of IL-33 in Immune-Mediated Scarring$0
I01 · FY2019 · VA · contact PI
The Mechanisms of Profibrotic Sensitization by IL33$345,375
R01 · FY2018 · HL · contact PI
Distinct regulation of pulmonary inflammation by isoforms of Interleukin-33$0
I01 · FY2017 · VA · contact PI
Distinct regulation of pulmonary inflammation by isoforms of Interleukin-33$0
I01 · FY2016 · VA · contact PI
Distinct regulation of pulmonary inflammation by isoforms of Interleukin-33$0
I01 · FY2015 · VA · contact PI
Distinct regulation of pulmonary inflammation by isoforms of Interleukin-33$0
I01 · FY2014 · VA · contact PI
Integrin-dependent mechanism of T cell-mediated pulmonary fibrosis$0
I01 · FY2012 · VA · contact PI
Integrin-dependent mechanism of T cell-mediated pulmonary fibrosis$0
I01 · FY2011 · VA · contact PI
INTEGRIN-DEPENDENT T CELL-MEDIATED MECHANISMS OF PULMONARY FIBROSIS$74,250
R03 · FY2010 · AR · contact PI
INTEGRIN-DEPENDENT T CELL-MEDIATED MECHANISMS OF PULMONARY FIBROSIS$75,000
R03 · FY2009 · AR · contact PI
Integrin-dependent mechanism of T cell-mediated pulmonary fibrosis$0
I01 · FY2009 · VA · contact PI
INTEGRIN-DEPENDENT T CELL-MEDIATED MECHANISMS OF PULMONARY FIBROSIS$75,000
R03 · FY2008 · AR · contact PI